Gene signature of breast cancer cell lines treated with lycopene

Area of Science:

• Nutritional Science
• Molecular Biology
• Oncology

Background:

• Lycopene, a potent antioxidant phytochemical, is abundant in tomatoes and tomato products.
• Emerging evidence suggests lycopene's potential role in cancer prevention, particularly breast cancer.
• Understanding the molecular mechanisms of lycopene's action is crucial for its therapeutic application.

Purpose of the Study:

• To investigate the effects of lycopene on gene expression in human breast cancer cell lines.
• To elucidate the molecular mechanisms underlying lycopene's potential breast cancer-preventive properties.
• To identify specific genes and pathways modulated by lycopene supplementation.

Main Methods:

• Oligonucleotide microarray analysis was employed to assess gene expression changes.
• Human breast cancer cell lines (MCF-7, MDA-MB-231) and a normal breast cell line (MCF-10a) were treated with 10 microM lycopene for 48 hours.
• Gene expression profiling of 202 selected genes was performed, followed by hierarchical clustering.

Main Results:

• Lycopene treatment induced cell line-specific modulation of gene expression in breast cells.
• Significant alterations in genes related to apoptosis, cell cycle regulation, and DNA repair were observed.
• The observed gene modulations were dependent on the estrogen and retinoic acid receptor status of the cells.

Conclusions:

• Lycopene influences key cellular processes, including apoptosis, cell cycle, and DNA repair, in breast cells.
• The effects of lycopene on gene expression are cell line-specific and influenced by cellular receptor status.
• Lycopene demonstrates potential as a breast cancer-preventive agent through modulation of critical molecular pathways.